Literature DB >> 12016245

Truths about the NINDS study: setting the record straight.

Jeffrey Mann1.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 12016245      PMCID： PMC1071714          DOI： 10.1136/ewjm.176.3.192

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


× No keyword cloud information.
  7 in total

1.  Understanding controlled trials: baseline imbalance in randomised controlled trials.

Authors:  C Roberts; D J Torgerson
Journal:  BMJ       Date:  1999-07-17

2.  Further randomized controlled trials of tPA within 3 hours are required-not!

Authors:  P D Lyden
Journal:  Stroke       Date:  2001-11       Impact factor: 7.914

3.  Thrombolytic therapy for acute ischemic stroke - Tissue plasminogen activator for acute ischemic stroke: Is the CAEP Position Statement too negative?

Authors:  J R Hoffman
Journal:  CJEM       Date:  2001-07       Impact factor: 2.410

4.  Progression in acute stroke: value of the initial NIH stroke scale score on patient stratification in future trials.

Authors:  T J DeGraba; J M Hallenbeck; K D Pettigrew; A J Dutka; B J Kelly
Journal:  Stroke       Date:  1999-06       Impact factor: 7.914

5.  Baseline NIH Stroke Scale score strongly predicts outcome after stroke: A report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST).

Authors:  H P Adams; P H Davis; E C Leira; K C Chang; B H Bendixen; W R Clarke; R F Woolson; M D Hansen
Journal:  Neurology       Date:  1999-07-13       Impact factor: 9.910

6.  Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study.

Authors:  J R Marler; B C Tilley; M Lu; T G Brott; P C Lyden; J C Grotta; J P Broderick; S R Levine; M P Frankel; S H Horowitz; E C Haley; C A Lewandowski; T P Kwiatkowski
Journal:  Neurology       Date:  2000-12-12       Impact factor: 9.910

7.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245
  7 in total
  8 in total

1.  How to spot bias and other potential problems in randomised controlled trials.

Authors:  S C Lewis; C P Warlow
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-02       Impact factor: 10.154

Review 2.  Thrombolysis in acute ischaemic stroke: a guide to patient selection.

Authors:  Richard I Lindley
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

3.  Why don't more patients receive intravenous rt-PA for acute stroke?

Authors:  Patrick Lyden
Journal:  Expert Rev Neurother       Date:  2015-05-04       Impact factor: 4.618

Review 4.  Fifty Years of Acute Ischemic Stroke Treatment: A Personal History.

Authors:  James C Grotta
Journal:  Cerebrovasc Dis       Date:  2021-10-14       Impact factor: 3.104

5.  Intra-arterial versus intra-venous thrombolysis within and after the first 3 hours of stroke onset.

Authors:  Srivastava Padma; Moonis Majaz
Journal:  Arch Med Sci       Date:  2010-06-30       Impact factor: 3.318

6.  Study of the neuroprotective effects of memantine in patients with mild to moderate ischemic stroke.

Authors:  Hamidreza Kafi; Jamshid Salamzadeh; Nahid Beladimoghadam; Mohammad Sistanizad; Mehran Kouchek
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

Review 7.  Thrombolysis for acute ischaemic stroke.

Authors:  Joanna M Wardlaw; Veronica Murray; Eivind Berge; Gregory J del Zoppo
Journal:  Cochrane Database Syst Rev       Date:  2014-07-29

8.  A user's guide to the NINDS rt-PA stroke trial database.

Authors:  Robert J Dachs; John H Burton; Jeremy Joslin
Journal:  PLoS Med       Date:  2008-05-20       Impact factor: 11.069
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.